Impact of Outsourcing on Ophthalmic Drug Manufacturing Market: Opportunities and Risks
The ophthalmic drugs contract manufacturing market involves companies engaged in contract manufacturing and packaging of prescription and non-prescription ophthalmic medications. Some key services offered by contract manufacturers include product formulation development, clinical trial support, regulatory approval, sterile liquid and ocular solid dosage filling, and packaging of drugs for treating eye diseases like glaucoma, infections, dry eyes, inflammation, and retinal disorders. Outsourcing manufacturing needs to well-established contract manufacturers enables pharmaceutical companies to reduce costs and focus on core areas of drug development and marketing.
Growing prevalence of eye diseases along with increasing adoption of outsourcing activities by pharmaceutical companies is expected to drive the demand for Ophthalmic Drugs Contract Manufacturing Market. According to the WHO, at least 2.2 billion people have a vision impairment or blindness, with cataract and uncorrected refractive errors being the leading causes.
Get more insights on: Ophthalmic Drugs Contract Manufacturing Market
Explore more related articles - Global Vein Illumination Devices Market - An Emerging Medical Device
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian